Should We Trust "Big Data" or "Meta-Data" to Guide Treatment for Patients with Resectable Esophageal Cancer?

J Am Coll Surg. 2017 May;224(5):996-997. doi: 10.1016/j.jamcollsurg.2017.01.046.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Adenocarcinoma*
  • Chemoradiotherapy
  • Esophageal Neoplasms*
  • Esophagogastric Junction
  • Humans
  • Neoadjuvant Therapy